Alpha-Catulin Contributes to Drug-Resistance of Melanoma by Activating NF-κB and AP-1

• Birgit Kreiseder ,

  Contributed equally to this work with: Birgit Kreiseder, Yvonne M Holper-Schichl

  Affiliation SeaLife Pharma GmbH, Tulln, Austria

  ⨯
• Yvonne M Holper-Schichl ,

  Contributed equally to this work with: Birgit Kreiseder, Yvonne M Holper-Schichl

  Affiliation Department of Vascular Biology and Thrombosis Research, Center for Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria

  ⨯
• Barbara Muellauer,

  Affiliation SeaLife Pharma GmbH, Tulln, Austria

  ⨯
• Nico Jacobi,

  Affiliation Medical and Pharmaceutical Biotechnology, University of Applied Sciences, Krems, Austria

  ⨯
• Alexander Pretsch,

  Affiliation SeaLife Pharma GmbH, Tulln, Austria

  ⨯
• Johannes A. Schmid,

  Affiliation Department of Vascular Biology and Thrombosis Research, Center for Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria

  ⨯
• Rainer de Martin,

  Affiliation Department of Vascular Biology and Thrombosis Research, Center for Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria

  ⨯
• Harald Hundsberger,

  Affiliation Medical and Pharmaceutical Biotechnology, University of Applied Sciences, Krems, Austria

  ⨯
• Andreas Eger,

  Affiliation Medical and Pharmaceutical Biotechnology, University of Applied Sciences, Krems, Austria

  ⨯
• Christoph Wiesner

  * E-mail: wiesner@sealifepharma.com

  Affiliations SeaLife Pharma GmbH, Tulln, Austria, Medical and Pharmaceutical Biotechnology, University of Applied Sciences, Krems, Austria

  ⨯